Inventor
MILLER MARK THOMAS
US42 patents
⚠️ This page may combine multiple inventors who share the name “MILLER MARK THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
33 patentsUS9974781B2May 22, 2018
Modulators of ATP-binding cassette transporters
VERTEX PHARMA30 citations98
US9550761B2Jan 24, 2017
Modulators of ATP-binding cassette transporters
VERTEX PHARMA43 citations98
US9321725B2Apr 26, 2016
Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
VERTEX PHARMA49 citations98
US9782408B2Oct 10, 2017
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA33 citations97
US8952050B2Feb 10, 2015
Modulators of ATP-binding cassette transporters
VERTEX PHARMA62 citations97
US8952049B2Feb 10, 2015
Modulators of ATP-binding cassette transporters
VERTEX PHARMA62 citations97
US10987348B2Apr 27, 2021
Modulators of ATP-binding cassette transporters
VERTEX PHARMA13 citations94
US10022352B2Jul 17, 2018
Modulators of ATP-binding cassette transporters
VERTEX PHARMA30 citations94
US10793547B2Oct 6, 2020
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA24 citations93
US10758534B2Sep 1, 2020
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA13 citations93
US10570115B2Feb 25, 2020
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA23 citations93
US10258624B2Apr 16, 2019
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA32 citations93
US9511067B2Dec 6, 2016
Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channels
VERTEX PHARMA17 citations92
US11591350B2Feb 28, 2023
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA7 citations85
US11584761B2Feb 21, 2023
Process of making CFTR modulators
VERTEX PHARMA9 citations85
US11426407B2Aug 30, 2022
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA6 citations85
US11873300B2Jan 16, 2024
Crystalline forms of CFTR modulators
VERTEX PHARMA6 citations84
US11453655B2Sep 27, 2022
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA8 citations84
US11186566B2Nov 30, 2021
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA10 citations84
US11066417B2Jul 20, 2021
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
VERTEX PHARMA13 citations84
US11414439B2Aug 16, 2022
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA6 citations74
US12421251B2Sep 23, 2025
Cystic fibrosis transmembrane conductance regulator modulating agents
VERTEX PHARMA5 citations73
US11866450B2Jan 9, 2024
Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
VERTEX PHARMA3 citations73
US12168009B2Dec 17, 2024
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA1 citations72
US10738030B2Aug 11, 2020
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA6 citations71
US12122788B2Oct 22, 2024
Process of making CFTR modulators
VERTEX PHARMA1 citations62
US12384762B2Aug 12, 2025
Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA0 citations61
US12319693B2Jun 3, 2025
Crystalline forms of CFTR modulators
VERTEX PHARMA0 citations61
US9181273B2Nov 10, 2015
Morpholine-spirocyclic piperidine amides as modulators of ion channels
VERTEX PHARMA0 citations51
US12324802B2Jun 10, 2025
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA0 citations48
US12269831B2Apr 8, 2025
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA0 citations48
US12503439B2Dec 23, 2025
Heteroaryl compounds for the treatment of pain
VERTEX PHARMA0 citations44
US9403839B2Aug 2, 2016
Pyran-spirocyclic piperidine amides as modulators of ion channels
VERTEX PHARMA0 citations41
HADIDA-RUAH SARA SABINA
5 patentsUS8318733B2Nov 27, 2012
Modulators of ATP-binding cassette transporters
HADIDA-RUAH SARA SABINA93 citations98
US8541453B2Sep 24, 2013
Modulators of ATP-binding cassette transporters
HADIDA-RUAH SARA SABINA74 citations97
US8598164B2Dec 3, 2013
Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
HADIDA-RUAH SARA SABINA5 citations71
US8828996B2Sep 9, 2014
Morpholine-spirocyclic piperidine amides as modulators of ion channels
HADIDA-RUAH SARA SABINA0 citations50
US9365588B2Jun 14, 2016
Benzoxazines as modulators of ion channels
HADIDA-RUAH SARA SABINA0 citations38